KH2014 Suositus KH2014 Suositus

Tulosta

Eri dyslipidemialääkkeet aivoverenkiertohäiriöiden ehkäisemiseksi ja hoidossa aivoverenkiertohäiriön jälkeen

Lisätietoa aiheesta
22.6.2006
Timo Strandberg

Statiinit

Fibraatit

Muut dyslipidemialääkkeet

Kirjallisuutta

  1. Bucher HC, Griffith LE, Guyatt GH. Effect of HMGcoA reductase inhibitors on stroke. A meta-analysis of randomized, controlled trials. Ann Intern Med 1998;128:89-95 «PMID: 9441587»PubMed
  2. Law MR, Wald NJ, Rudnicka AR. Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease and stroke: systemic review and meta-analysis. Br Med J 2003;326:1407-8
  3. Collins R, Armitage J, Parish S ym. Effects of cholesterol-lowering with simvastatin on stroke and other major vascular events in 20536 people with cerebrovascular disease or other high-risk conditions. Lancet 2004;363:757-67 «PMID: 15016485»PubMed
  4. Sever PS, Dahlöf B, Poulter NR ym. Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial--Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial. Lancet 2003;361:1149-58 «PMID: 12686036»PubMed
  5. Colhoun HM, Betteridge DJ, Durrington PN ym. Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial. Lancet 2004;364:685-96 «PMID: 15325833»PubMed
  6. LaRosa JC, Grundy SM, Waters DD ym. Intensive lipid lowering with atorvastatin in patients with stable coronary disease. N Engl J Med 2005;352:1425-35 «PMID: 15755765»PubMed
  7. Baigent C, Keech A, Kearney PM ym. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet 2005;366:1267-78 «PMID: 16214597»PubMed
  8. De Backer G, Ambrosioni E, Borch-Jensen K ym. Eurooppalainen suositus sydän- ja verisuonitautien ehkäisystä käytännön lääkärin työssä. Suom Lääkäril 2004;59:2120-8
  9. Pedersen TR, Faergeman O, Kastelein JJ ym. High-dose atorvastatin vs usual-dose simvastatin for secondary prevention after myocardial infarction: the IDEAL study: a randomized controlled trial. JAMA 2005;294:2437-45 «PMID: 16287954»PubMed
  10. Bonetti PO, Lerman LO, Napoli C ym. Statin effects beyond lipid lowering--are they clinically relevant? Eur Heart J 2003;24:225-48 «PMID: 12590901»PubMed
  11. Robinson JG, Smith B, Maheshwari N ym. Pleiotropic effects of statins: benefit beyond cholesterol reduction? A meta-regression analysis. J Am Coll Cardiol 2005;46:1855-62 «PMID: 16286171»PubMed
  12. Bucher HC, Griffith LE, Guyatt GH. Effect of HMGcoA reductase inhibitors on stroke. A meta-analysis of randomized, controlled trials. Ann Intern Med 1998;128:89-95 «PMID: 9441587»PubMed
  13. Bloomfield Rubins H, Davenport J, Babikian V ym. Reduction in stroke with gemfibrozil in men with coronary heart disease and low HDL cholesterol: The Veterans Affairs HDL Intervention Trial (VA-HIT). Circulation 2001;103:2828-33 «PMID: 11401940»PubMed
  14. Keech A, Simes RJ, Barter P ym. Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial. Lancet 2005;366:1849-61 «PMID: 16310551»PubMed
Käypä hoito -suositukset ovat riippumattomia, tutkimusnäyttöön perustuvia kansallisia hoitosuosituksia. Lue lisää
LINKKIEN TYYPIT JA VÄRIKOODIT
Kirjallisuusviite
Kuva
Linkki toiselle sivustolle
Lisätietoa
Näytönastekatsaus
PDF-tiedosto
PubMed-abstrakti
Taulukko